As large Korean CDMO companies, including Samsung Biologics and Lotte Biologics, vie to expand manufacturing facilities, their competition has moved to recruit a specialized workforce, an industry group said.In its Issue Briefing on Monday, KoreaBIO pointed to the shortage of experienced workers in
SK Bioscience said it had demonstrated global-level performance in ESG (environmental, social, and corporate governance) management, but the company’s rating in the MSCI ESG rating remained at an average level, it was learned.In a news release Friday, SK Bioscience said it won a BBB rating in the ES
Lotte Biologics said it is opting to build its mega plant in Songdo, Incheon.Lotte Biologics said it had submitted a letter of intent to Songdo International Business District (IBD).“We submitted documents indicating our intention to build our operation base in Songdo,” a company official said. “The
KAIST said on Wednesday that its researchers identified a post-translational modification (PTM) code that can help to suppress cancer and other brain-related diseases.PTM refers to the translation process of the mRNA molecule into the final protein which affects its structure and efficacy of the pro
NewG Lab Pharma's stock price plunged by nearly 50 percent in two days, raising questions among industry watchers.At 11 a.m. Monday, the company shares stood at 6,560 won ($5.33), down by 1,560 won, or 19.41 percent, from 8,140 won the previous trading day’s closing price.The stock price of NewG Lab
Large traditional Korean pharmaceutical companies, such as Chong Kun Dang, Dong-A ST, and Samchundang Pharmaceutical, are accelerating their entry into the biosimilar market.According to industry watchers, local pharmaceutical companies are zeroing in on the growth potential of biosimilars as blockb
Two Kosdaq-listed companies, Avion and Gencurix, have been accused of violating trade secrets on cancer diagnosis-related technology in the United States.According to industry sources on Monday, trade secrets infringement lawsuits against Avion and Zencurix are currently underway in U.S. courts. The
Korea Advanced Institute of Science & Technology (KAIST) said on Monday that its researchers published a study on a technology that can change the properties of lung cancer cells to revert metastasis and lower drug resistance.The epithelial-to-mesenchymal transition (EMT) of primary cancer leads to
CJ Bioscience continued to show sluggish performance in 2022 even after CJ Group, a Korean conglomerate, acquired the company.CJ Group acquired Chunlab, which specializes in microbiome treatment, in January last year and restarted its bio-business after renaming the company to CJ Bioscience.At that
Koreans in their 30s and 40s will likely be the first generation to age faster than their parents because they are exposed to an “accelerated aging environment,” an expert said.Professor Jung Hee-won of Geriatric Medicine at Asan Medical Center (AMC) in Seoul said so at a round-table meeting hosted
SK Bioscience said CEO Ahn Jae-yong presented global partnership strategies for overcoming the next pandemic by establishing regional vaccine hubs at the 2023 Riyadh Global Medical Biotechnology Summit in Riyadh, Saudi Arabia, on Wednesday.The Riyadh Summit is a national event where global bioindust
HK inno.N said it has signed an exclusive license agreement with Spain's mAbxience to market the latter's Prolia (ingredient: denosumab) biosimilar, a preventive treatment for osteoporosis and cancer-related skeletal complications, in Korea.Under the contract, HK inno.N will exclusively market two t
Celltrion said it had increased its stake in Iksuda Therapeutics, a U.K.-based antibody-drug conjugate (ADC) developer, to 47.05 percent through direct investment and Mirae Asset-Celltrion New Growth Fund 1.As a result, Celltrion and the new growth fund rose to become the largest shareholders of Iks
A team of researchers at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) has developed a CRISPRi-based plasmid selection system by building a cascaded logic inverter to mimic antibiotics and thereby reduce antibiotic-resistance genes.Antibiotic screening is most widely used to s
With their biosimilars, Samsung Bioepis and Chong Kun Dang will soon compete to secure a larger ranibizumab market share for treating wet age-related macular degeneration in Korea. The wet age-related macular degeneration (wAMD) treatment market is expected to see fierce competition this year as Sam
Daewoong Bio is planning to enter the contract development and manufacturing organization (CDMO) business through large-scale investment.Daewoong Bio said Monday that it will invest 146 billion won ($117.9 million) to build a new biological drug plant in Hyangnam, Gyeonggi Province, where the compan
A research team at Yonsei University College of Medicine published a study, saying the delivery of antibody treatments like aducanumab can be improved 8.1 times with focused ultrasound (FUS) targetted to the blood-brain barrier (BBB) of mice.Alzheimer's is known to be associated with the accumulatio
SAN FRANCISCO, Calif. -- By Lee Han-soo/Korea Biomedical Review correspondent – Samsung Biologics unveiled its aspiration to become a top-tier global biopharmaceutical company by 2030 during the 2023 J.P. Morgan Healthcare Conference's Main Track on Wednesday. John Rim, CEO of the biotech unit of Sa
A team of researchers at the Ajou University School of Medicine conducted a study on inhaled corticosteroid (ICS)-formoterol treatments and found that they can effectively prevent the occurrence of serious asthmatic exacerbations.The study cohort included 743 adult asthma patients who received asthm
Researchers in Korea said they discovered a new immune checkpoint inhibitor called NgR1 which suppresses the activity of natural killer (NK) cells in cancer.Surgery, radiation therapy, and chemotherapy have been used as major treatments for cancer. However, many cancer patients suffer from physical